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Recently, intravitreal injection of triamcinolone acetonide
(TA) has been widely used for treating many ocular
disorders [1–4]. Although several studies have confirmed
its efficacy and safety, TA has been associated with
potential complications, which include endophthalmitis
[5,6], retinal detachment [6,7], vitreous hemorrhage [8],
cataract formation, and elevated intraocular pressure
(IOP) [6–8]. Although it is rare, infectious endophthalmitis
is one of the most severe complications after TA.
Immediate and proper treatment is critical for preventing
visual impairment. Therefore, care must be taken by
ophthalmologists to differentiate between infectious and
noninfectious endophthalmitis. Herein, we report on a
patient who developed a hypopion 1 day after intravitreal
injection of TA for central retinal vein occlusion (CRVO).
In our case, the hypopion resolved completely by the
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fifth postoperative day, without recourse to the
administration of intravitreal or systemic antibiotic
therapy.
CASE PRESENTATION
A 62-year-old, obese, hypertensive woman visited our
hospital because of a 3-day history of visual decrease in
her left eye. Her best corrected visual acuity was 20/200
in the left eye and 20/25 in the right eye. Anterior segment
examination was unremarkable, except for mild nuclear
sclerosis cataracts in both eyes. IOP was normal in both
eyes, but the patient was diagnosed with an acute CRVO
in the left eye. After being advised of the risks and
benefits, the patient received an intravitreal injection of
TA (4mg/0.1 mL) in the left eye. One day after surgery,
she was found to have white–yellowish deposits
(hypopion) in the inferior anterior chamber (Figure 1).
Fundus examination by a Goldmann 3-mirror contact
lens showed some white, crystalline deposits of TA in the
inferior vitreous cavity, and an absence of inflammatory
vitreous cells.
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The patient complained that her vision had
deteriorated, but there was no pain, eyelid edema, increased
conjunctival injection or corneal edema. Topical antibiotic
and steroid eye drops were administered 4 times daily,
and no intravitreal, systemic or additional topical
antibiotics were given. She was followed on a daily basis,
and her visual acuity returned to the preinjection level by
the third postoperative day. The hypopion in the inferior
anterior chamber gradually diminished over the
subsequent examinations, and resolved completely by the
fifth postoperative day (Figure 2).
DISCUSSION
In general, the presence of hypopion following intraocular
surgery may herald the onset of infectious endophthalmitis,
as both infectious and noninfectious endophthalmitis after
intravitreal TA injection have been reported [5,6,9–12].
Therefore, it is very important to differentiate between an
infectious event from a noninfectious event, especially when
a hypopion is present.
In our patient, we concluded that the patient presented
with noninfectious endophthalmitis because: (1) there was
an acute onset without pain, eyelid edema, increased
conjunctival chemosis or injection or corneal edema, whereas
infectious endophthalmitis typically presents acutely or
subacutely with the aforementioned manifestations, and
these manifestations were not observed on the subsequent
examinations. We, therefore, did not perform anterior
chamber tapping or vitreous culture to confirm the
components of hypopion; (2) the visual acuity in our patient
rapidly returned to the level of preinjection and the hypopion
gradually diminished in size within days of developing the
hypopion; it is possible that the true course of the infection
was masked by the intravitreal steroid, but this seemed
unlikely without the fortified or intravitreal antibiotic cover;
and (3) the vitreous cavity was free of inflammatory cells
and was observed without progressive inflammation or
any signs of infection.
Nevertheless, one case can not prove clear evidence
between hypopion and noninfectious endophthalmitis after
intravitreal TA injection. However, this report may alert
ophthalmologists to carefully follow up their patients with
hypopion after intravitreal TA injection, to rule out
progressive inflammation due to early infectious
endophthalmitis.
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Figure 1. Hypopion (white–yellowish deposits) (arrow), in the inferior
anterior chamber 1 day after intravitreal triamcinolone acetonide injection
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Figure 2. Hypopion (white–yellowish deposits) in the inferior anterior
chamber resolved completely on the fifth postoperative day.
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